MediCarbone
MediCarbone is an Arizona-based orthopedic medical device startup founded in 2019, focused on revolutionizing bone fracture repair through minimally invasive, customized intramedullary nailing technology. The company utilizes patented carbon-fiber-reinforced polymer applications and AI technology to enhance patient outcomes in orthopedic treatments.
MediCarbone
2820 E Fort Lowell Rd, Tucson, Arizona 85716, USA
Patents
Methods for creating, inserting, and removing an intramedullary sleeve system for bone treatment and stabilization
2024-03-12 • US-11925394-B1
View DetailsMethod of creating biocompatible polymeric resin systems for bone repair and management
2024-03-12 • US-11925401-B1
View Details
Methods for creating, inserting, and removing an intramedullary sleeve system for bone treatment and stabilization
2024-03-12 • US-11925394-B1
View DetailsMethod of creating biocompatible polymeric resin systems for bone repair and management
2024-03-12 • US-11925401-B1
View DetailsWhat We Do
MediCarbone’s intramedullary fixation device consists of a carbon-fiber-reinforced sleeve and an injectable, rapid-cure polymeric resin system, providing a minimally invasive alternative to traditional intramedullary nailing techniques.
MediCarbone’s intramedullary fixation device consists of a carbon-fiber-reinforced sleeve and an injectable, rapid-cure polymeric resin system, providing a minimally invasive alternative to traditional intramedullary nailing techniques.
Application Area
Key People
News & Updates
MediCarbone will be in attendance at the Orthopedic Research Society Annual Meeting (ORS), February 2-6, 2024 at the Long Beach Convention Center in Long Beach, CA.
MediCarbone announced it received an NSF SBIR Phase I award for $273,563 for the design and development of its minimally-invasive orthopedic fracture fixation technology.
MediCarbone received an NSF SBIR Phase I award for $273,563 to support the development of its innovative orthopedic fracture fixation technology.
MediCarbone has 1 licensed patent from the University of Arizona; 2 patents approved for publishing and many others in the works, focusing on methods for treating bone fractures and systems for bone repair.
MediCarbone will be in attendance at the Orthopedic Research Society Annual Meeting (ORS), February 2-6, 2024 at the Long Beach Convention Center in Long Beach, CA.
MediCarbone announced it received an NSF SBIR Phase I award for $273,563 for the design and development of its minimally-invasive orthopedic fracture fixation technology.
MediCarbone received an NSF SBIR Phase I award for $273,563 to support the development of its innovative orthopedic fracture fixation technology.
MediCarbone has 1 licensed patent from the University of Arizona; 2 patents approved for publishing and many others in the works, focusing on methods for treating bone fractures and systems for bone repair.